E. Welshman

Fetal fibronectin results did not reduce medical resource use for women with preterm uterine contractions

W. Grobman, E. Calhoun, P. Ramsey, 2005 .

Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial.

W. Grobman, E. Calhoun, E. Welshman, 2004, American journal of obstetrics and gynecology.

A comparison of ovarian cancer treatments: analysis of utility assessments of ovarian cancer patients, at-risk population, general population, and physicians.

D. Fishman, C. Bennett, E. Calhoun, 2004, Gynecologic oncology.

Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (Fact/GOG‐Ntx) questionnaire for patients receiving systemic chemotherapy

D. Fishman, D. Cella, T. Hunt, 2003, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy

D. Fishman, D. Cella, T. Hunt, 2003, International Journal of Gynecologic Cancer.

Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients.

D. Fishman, C. Bennett, E. Calhoun, 2001, The oncologist.

Investigating the Possible Effects of Tomatoes or Lycopene in Preventing Prostate Cancer

Young L. Kim, G. Borisy, V. Backman, 2004 .

Preference assessment of prenatal diagnosis for Down syndrome: is 35 years a rational cutoff?

E. Pergament, W. Grobman, S. Dooley, 2002, Prenatal diagnosis.

Taxane-induced alopecia: A historical review of patients with ovarian or breast cancer treated with with paclitaxel, docetaxel or paclitaxel poliglumex

E. Calhoun, E. Welshman, S. Brown, 2005 .